Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nagase & Co., Ltd. is a prominent Japanese chemical trading and manufacturing company with a deep focus on the life sciences and healthcare industries. Established in 1832, the company operates as a global distributor and manufacturer of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and functional food ingredients. Through its specialized subsidiaries, Nagase provides contract development and manufacturing organization (CDMO) services, as well as research into biotechnology and enzyme production. The company serves as a critical link in the global pharmaceutical supply chain, offering technical expertise and logistics across Asia, North America, and Europe. Nagase is publicly traded on the Tokyo Stock Exchange and continues to expand its R&D capabilities through strategic acquisitions and internal innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nagas and Co.